Literature DB >> 10400258

Clinical understanding and clinical implications of response shift.

I B Wilson1.   

Abstract

The purpose of this paper is to provide clinical understanding and clinical context for the concept of response shift. First, the paper describes a variety of target constructs or dimensions of health-related quality of life that are important in clinical medicine, including biological and physiological measures, symptoms, functioning, general health perceptions and overall quality of life. It is argued that insight into response shift can be gained by assessing the ways in which measures on these different dimensions change relative to each other. Second, somatization and hypochondriasis are presented as examples of clinical circumstances in which appropriate and adaptive response shifts do not occur. Third, placebo effects are defined and it is argued that response shift is one subtype of placebo effect. Finally, the role of response shift in routine clinical care and its implication for the physician-patient relationship are discussed. Although it cannot and should not replace careful attention to and appropriate treatment of abnormal biological and physiological processes, there are times when explicit attempts to produce response shifts may complement these biomedical therapies. Producing response shift probably involves understanding the psychological, social and cultural context of the illness; may be mediated by the physician-patient relationship and may facilitate coping processes in ways that improve health-related quality of life.

Entities:  

Mesh:

Year:  1999        PMID: 10400258     DOI: 10.1016/s0277-9536(99)00050-7

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  29 in total

1.  Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study.

Authors:  T S Dabakuyo; F Guillemin; T Conroy; M Velten; D Jolly; M Mercier; S Causeret; J Cuisenier; O Graesslin; M Gauthier; F Bonnetain
Journal:  Qual Life Res       Date:  2012-03-01       Impact factor: 4.147

2.  Abandoning the language of "response shift": a plea for conceptual clarity in distinguishing scale recalibration from true changes in quality of life.

Authors:  Peter A Ubel; Yvette Peeters; Dylan Smith
Journal:  Qual Life Res       Date:  2010-01-29       Impact factor: 4.147

3.  Response shift: a brief overview and proposed research priorities.

Authors:  Ruth Barclay-Goddard; Joshua D Epstein; Nancy E Mayo
Journal:  Qual Life Res       Date:  2009-02-25       Impact factor: 4.147

4.  Health-related quality of life in patients with serious non-specific symptoms undergoing evaluation for possible cancer and their experience during the process: a mixed methods study.

Authors:  E Moseholm; S Rydahl-Hansen; B Ø Lindhardt; M D Fetters
Journal:  Qual Life Res       Date:  2016-10-04       Impact factor: 4.147

5.  Palliative care or end-of-life care in advanced chronic obstructive pulmonary disease: a prospective community survey.

Authors:  Patrick White; Suzanne White; Polly Edmonds; Marjolein Gysels; John Moxham; Paul Seed; Cathy Shipman
Journal:  Br J Gen Pract       Date:  2011-06       Impact factor: 5.386

6.  Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public.

Authors:  Peter A Ubel; George Loewenstein; Christopher Jepson
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

7.  A prospective study of quality of life in patients undergoing pelvic exenteration: interim results.

Authors:  Youssef A Rezk; Karen E Hurley; Jeanne Carter; Fanny Dao; Bernard H Bochner; Janice J Aubey; Aileen Caceres; M Heather Einstein; Nadeem R Abu-Rustum; Richard R Barakat; Vicky Makker; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2012-10-09       Impact factor: 5.482

8.  Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer.

Authors:  Kristine A Donovan; Paul B Jacobsen; Michael A Andrykowski; Erin M Winters; Lodovico Balducci; Uzma Malik; Daniel Kenady; Patrick McGrath
Journal:  J Pain Symptom Manage       Date:  2004-10       Impact factor: 3.612

9.  Problems eliciting cues in SEIQoL-DW: quality of life areas in small-cell lung cancer patients.

Authors:  Marjan Westerman; Tony Hak; Anne-Mei The; Harry Groen; Gerrit van der Wal
Journal:  Qual Life Res       Date:  2006-04       Impact factor: 4.147

Review 10.  The placebo effect: illness and interpersonal healing.

Authors:  Franklin G Miller; Luana Colloca; Ted J Kaptchuk
Journal:  Perspect Biol Med       Date:  2009       Impact factor: 1.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.